Aquestive Therapeutics (NASDAQ:AQST) executives outlined the company’s near-term regulatory plans and longer-term platform strategy during a presentation at Oppenheimer’s 36th Annual Healthcare Life ...
(CNN) — The US Food and Drug Administration approved the first nasal spray epinephrine drug for severe allergic reactions known as anaphylaxis, providing a needle-free alternative to EpiPens and ...
(CNN) — The US Food and Drug Administration approved the first nasal spray epinephrine drug for severe allergic reactions known as anaphylaxis, providing a needle-free alternative to EpiPens and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results